December 18, 2017 Press release - Regulatory Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer
December 11, 2017 Press release - Regulatory Targovax announces that first combination trials with ONCOS-102 have passed their initial, planned, independent safety reviews
November 3, 2017 Press release - Regulatory Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA
October 27, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
October 24, 2017 Press release - Regulatory Targovax ASA: Invitation to third quarter 2017 results presentation Thursday 2 November
October 12, 2017 Press release - Regulatory Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer
October 3, 2017 Press release - Regulatory Targovax granted US Patent for mutant-RAS neoantigen platform 2nd generation product TG02
September 25, 2017 Press release - Regulatory Targovax granted US Patent for mutant-RAS neoantigen platform lead products
September 12, 2017 Press release - Regulatory Targovax announces start of patient recruitment in phase I/II study with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies
September 11, 2017 Press release - Non-regulatory Targovax ASA: Three posters presented at ESMO conference
August 29, 2017 Press release - Regulatory Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units
August 28, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs
August 25, 2017 Press release - Regulatory Exercise of employee share options and restricted stock units in Targovax ASA
August 23, 2017 Press release - Non-regulatory Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress
August 18, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
August 14, 2017 Press release - Regulatory Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August
July 14, 2017 Press release - Regulatory Targovax ASA: Last day of the subscription period in the subsequent offering
July 6, 2017 Press release - Regulatory Targovax ASA: Registration of share capital increase following the private placement
July 3, 2017 Press release - Regulatory Targovax ASA: Commencement of subscription period for the subsequent offering
June 30, 2017 Press release - Regulatory Targovax ASA: Approval and publication of prospectus; the subsequent offering
June 30, 2017 Press release - Regulatory Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering
June 26, 2017 Press release - Regulatory Targovax ASA: Registration of capital increase following exercise of employee options and settlement of restricted stock units
June 22, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in relation to exercise of employee options
June 22, 2017 Press release - Regulatory Targovax ASA: Exercise of employee share options and settlement of restricted stock units in Targovax ASA
June 15, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of vested restricted stock units
June 14, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
June 9, 2017 Press release - Regulatory Targovax ASA – Information on the subsequent offering – Key date information
June 6, 2017 Press release - Regulatory Targovax presents further positive clinical data from TG01 phase I/II trial at 2017 ASCO annual meeting
June 6, 2017 Press release - Regulatory Targovax announces formal agenda for 2017 Capital Markets Updates in Oslo and London
May 10, 2017 Press release - Regulatory Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study
May 8, 2017 Press release - Regulatory Targovax ASA: Capital Markets Updates in Oslo on Thursday 8 June and in London on Monday 26 June 2017
April 28, 2017 Press release - Regulatory Targovax ASA: Issuance of restricted stock unites (RSUs) to the board members
April 20, 2017 Press release - Regulatory Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform
April 19, 2017 Press release - Regulatory Targovax ASA: Invitation to first quarter 2017 results presentation Tuesday 25 April
April 6, 2017 Press release - Regulatory Targovax to present clinical data on its phase I/II clinical trial evaluating TG01 in resected pancreatic cancer at the ASCO Annual Meeting
April 4, 2017 Press release - Regulatory Targovax ASA: Proposal from the nomination committee to the annual general meeting 5 April 2017
March 22, 2017 Press release - Regulatory Targovax ASA: The board of directors of Oslo Stock Exchange approves transfer of Targovax ASA to the main list
March 17, 2017 Press release - Regulatory Targovax ASA applies for transfer to Oslo Stock Exchange main list
February 24, 2017 Press release - Regulatory Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units
February 24, 2017 Press release - Regulatory Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA
February 13, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of restricted stock units
February 10, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
February 6, 2017 Press release - Regulatory Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February
February 2, 2017 Press release - Regulatory Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients
January 5, 2017 Press release - Regulatory Targovax announces appointment of Erik Digman Wiklund as CFO
